venlafaxine hydrochloride has been researched along with Cognitive Dysfunction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hantson, P; Haufroid, V; Volon, B; Willemart, T | 1 |
| Aizenstein, HJ; Butters, MA; Droppa, K; Karim, HT; Karp, JF; Reynolds, CF; Tudorascu, DL | 1 |
| Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS | 1 |
| Etkin, A; Gyurak, A; Harris, A; Shilyansky, C; Usherwood, T; Williams, LM | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
1 trial(s) available for venlafaxine hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
4 other study(ies) available for venlafaxine hydrochloride and Cognitive Dysfunction
| Article | Year |
|---|---|
Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.
Topics: Antidepressive Agents; Cognitive Dysfunction; Cytochrome P-450 CYP2D6; Depression; Humans; Male; Middle Aged; Polymorphism, Genetic; Recurrence; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2019 |
Association between change in brain gray matter volume, cognition, and depression severity: Pre- and post- antidepressant pharmacotherapy for late-life depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Cognitive Dysfunction; Depressive Disorder, Major; Female; Follow-Up Studies; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Outcome Assessment, Health Care; Prefrontal Cortex; Severity of Illness Index; Venlafaxine Hydrochloride | 2017 |
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2014 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |